Arizona Tribune - UniDoc Completes Purchase of AGNES Connect(R) Software from AMD Telemedicine

"The AGNES Connect software forms the foundation of UniDoc's NEIL Connect software platform, and I am excited to complete this acquisition and bring the ownership and future development of this software in house. Additionally, AGNES Connect has been in commercial operation for several years and has established a national and international customer network. We look forward to supporting current subscribers and to build upon this existing customer base. For UniDoc, AGNES Connect represents an additional opportunity to generate sustainable revenue for the company," states CEO Antonio Baldassarre.

Pursuant to the terms of a definitive purchase agreement dated March 18, 2025, UniDoc has acquired from AMD several assets including the name "AMD Telemedicine" and related goodwill, the AGNES Connect software, and related intellectual property, customer subscriptions and accounts. As consideration, the Company paid AMD US$175,000 in cash plus a revenue share.

On Behalf of the Board of Directors,

~Antonio Baldassarre~

Antonio Baldassarre
CEO, President & Director
UniDoc Health Corp.

About UniDoc Health Corp. (CSE:UDOC)(FRA:L7T)(OTCQB:UDOCF)

UniDoc is developing an eHealth solution which is being designed as a self-contained remote virtual clinic within a private kiosk for patients to undergo full consultations as if they were present in a physician's office. eHealth opens the doors to a large segment of the population challenged by access, experience or understanding of online computer technology. It is the Company's belief that physical accessibility is the key to its business proposition. UniDoc is dedicated to unlocking shareholder value by delivering an excellent product and sophisticated commercial network within an expedited timeframe. The UniDoc team encourages engagement, questions, and interest, so please stay in touch and invite anyone who might be interested in our story to visit our website at www.unidoctor.com and signup to receive the latest information with updates on our activities, events and progress.

For further information, please contact:

UniDoc Investor Relations
Tel: +1 778.383.6731
Email: info@unidoctor.com

Matt Chatterton, Director
Tel: +1 778.613.2082
Email: matt@unidoctor.com

Media Inquiries media@unidoctor.com

Forward-Looking Statements

Certain information contained herein constitutes "forward-looking information" under Canadian securities legislation. Generally, forward-looking information can be identified by the use of forward-looking terminology such as "anticipates", "anticipated" "expected" "intends" "will" or variations of such words and phrases or statements that certain actions, events or results "will" occur. Forward-looking statements are based on the opinions and estimates of management as of the date such statements are made and they are from those expressed or implied by such forward-looking statements or forward-looking information subject to known and unknown risks, uncertainties and other factors that may cause the actual results to be materially different, including receipt of all necessary regulatory approvals. Although management of the Company have attempted to identify important factors that could cause actual results to differ materially from those contained in forward-looking statements or forward-looking information, there may be other factors that cause results not to be as anticipated, estimated or intended. There can be no assurance that such statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in such statements. Accordingly, readers should not place undue reliance on forward-looking statements and forward-looking information. The Company will not update any forward-looking statements or forward-looking information that are incorporated by reference herein, except as required by applicable securities laws.

The CSE does not accept responsibility for the adequacy or accuracy of this release.

SOURCE: UniDoc Health Corp.

View the original press release on ACCESS Newswire

S.Jackson--AT